Description: Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.
Home Page: singulargenomics.com
OMIC Technical Analysis
10931 North Torrey Pines Road
La Jolla,
CA
92037
United States
Phone:
858 333 7830
Officers
| Name | Title |
|---|---|
| Mr. Andrew Spaventa | Founder, CEO, Pres & Chairperson of the Board |
| Dr. David L. Barker Ph.D. | Founder, Member of Scientific Advisory Board & Independent Director |
| Ms. Daralyn Durie | Gen. Counsel |
| Dr. Eli N. Glezer Ph.D. | Founder, Chief Scientific Officer & Chair of Scientific Advisory Board |
| Mr. Dalen Meeter | Sr. VP of Fin. & CFO |
| Mr. Jorge Velarde Jr., MBA | Sr. VP of Corp. Devel. & Strategy |
| Mr. Jeff Bullard | Head of Sales |
| Mr. Vincent Brancaccio | Sr. VP of HR |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 19.3 |
| Price-to-Book MRQ: | 0.611 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-05-27 |
| Fiscal Year End: | December |
| Full Time Employees: | 269 |